6 articles2,176 citations
Soft Tissue and Visceral Sarcomas: Esmo–euracan–genturis Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up
Gronchi, Stacchiotti·Annals of Oncology·2021·901 citations
Comparison of MAPIE versus MAP in Patients with a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (EURAMOS-1): An Open-Label, International, Randomised Controlled Trial.
Marina, Whelan·The Lancet. Oncology·2016·531 citations
Bone Sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up.Citation only
Strauss, Stacchiotti·Ann Oncol·2021·492 citations
Comparison of Two Chemotherapy Regimens in Patients with Newly Diagnosed Ewing Sarcoma (EE2012): An Open-Label, Randomised, Phase 3 Trial.Citation only
Brennan, Wheatley·Lancet·2022·139 citations
Can Postoperative Radiotherapy Be Omitted in Localised Standard-Risk Ewing Sarcoma? An Observational Study of the Euro-E.w.i.n.g Group.Citation only
Foulon, Le Deley·Eur J Cancer·2016·95 citations
Identifying Consensus and Areas for Future Research in Chondrosarcoma : A Report from the Birmingham Orthopaedic Oncology Meeting.Citation only
Jeys, Campanacci·Bone Joint J·2025·18 citations